Overview
| Alternate Names: | Serotonin N-acetyltransferase; serotonin N-acetyltransferase |
|---|---|
| Alternate Symbols: | AA-NAT; SNAT |
| PharmGKB Accession Id: | PA24366 |
Details
| Cytogenetic Location: | chr17 : q25.1 |
|---|---|
| GP mRNA Boundary†: | chr17 : 71975246 - 71977794 |
| GP Gene Boundary†: | chr17 : 71965246 - 71980794 |
| Strand: | plus |
| Product Name: | arylalkylamine N-acetyltransferase, serotonin N-acetyltransferase |
†
The mRNA boundaries are calculated using the gene's default feature set from NCBI, mapped
onto the UCSC Golden Path. PharmGKB sets gene boundaries by expanding the mRNA boundaries
by no less than 10,000 bases upstream (5') and 3,000 bases downstream (3') to allow for
potential regulatory regions.
Non-Curated Information
A list of non-curated publications that mention this gene along with other drugs is available.
LinkOuts
- Ref Seq NT Accession:
- AC_000060
- AC_000149
- NC_000017
- NT_010641
- NW_001838454
- NW_926918
- UniProtKB Accesssion:
- SNAT_HUMAN (Q16613)
- Ensembl ID:
- ENSG00000129673
- GenAtlas ID:
- AANAT
- GeneCard ID:
- AANAT